000 01349 a2200421 4500
005 20250512201222.0
264 0 _c19820326
008 198203s 0 0 eng d
022 _a0042-9007
024 7 _a10.1111/j.1423-0410.1981.tb01051.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDwyer, J M
245 0 0 _aRemoval of thymic-derived lymphocytes during pheresis procedures.
_h[electronic resource]
260 _bVox sanguinis
_c
300 _a287-94 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aBlood Donors
650 0 4 _aCentrifugation
650 0 4 _aDexamethasone
_xpharmacology
650 0 4 _aFemale
650 0 4 _aGranulocytes
_xtransplantation
650 0 4 _aHumans
650 0 4 _aHydroxyethyl Starch Derivatives
_xpharmacology
650 0 4 _aLeukapheresis
_xadverse effects
650 0 4 _aLeukocyte Count
650 0 4 _aLymphocyte Activation
650 0 4 _aLymphopenia
_xetiology
650 0 4 _aMale
650 0 4 _aPlatelet Transfusion
650 0 4 _aPrednisone
_xpharmacology
650 0 4 _aT-Lymphocytes
_xphysiology
650 0 4 _aUltrafiltration
700 1 _aWade, M J
700 1 _aKatz, A J
773 0 _tVox sanguinis
_gvol. 41
_gno. 5-6
_gp. 287-94
856 4 0 _uhttps://doi.org/10.1111/j.1423-0410.1981.tb01051.x
_zAvailable from publisher's website
999 _c6172950
_d6172950